Sadly, at least at the moment, yes - although the trainer pointed out this is actually because no-one wants to do the real-patient research on pace-maker patients, just in case, rather than there being any proof that it would give a problem.
Currently we are only going to be using it on patients that have had no result from, or bad side effects to, both oral and transdermal medication (transdermal being 'patches' - in this case oxybutinin patches - Kentera). The meds are safe with pacemakers if you tolerate them well. Otherwise the next step might have to be botox injections into the bladder wall...
But, hopefully, they might clear PTNS for people with pacemakers eventually.
no subject
Date: 19/03/2012 10:08 pm (UTC)Currently we are only going to be using it on patients that have had no result from, or bad side effects to, both oral and transdermal medication (transdermal being 'patches' - in this case oxybutinin patches - Kentera). The meds are safe with pacemakers if you tolerate them well. Otherwise the next step might have to be botox injections into the bladder wall...
But, hopefully, they might clear PTNS for people with pacemakers eventually.